Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-03-08
2005-03-08
Harris, Alana M. (Department: 1642)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C435S004000, C435S006120, C435S007100, C435S007210, C435S007230, C435S069100, C435S070100, C435S070200, C435S070210, C514S001000, C514S002600, C514S008100, C514S012200, C514S042000, C514S043000, C514S04400A, C530S300000, C530S350000, C530S385000, C530S387100, C530S387700, C530S387900, C530S388100, C536S001110, C536S018700, C536S023400, C536S023500
Reexamination Certificate
active
06863892
ABSTRACT:
A novel gene (designated 158P1D7) and its encoded protein are described. While 158P1D7 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1D7 provides a diagnostic and/or therapeutic target for cancers. The 158P1D7 gene or fragment thereof, or its encoded protein or a fragment thereof, can be used to elicit an immune response.
REFERENCES:
patent: 20020192678 (2002-12-01), Chen
patent: 20040033504 (2004-02-01), Agarwal et al.
patent: 1033401 (2000-09-01), None
patent: 1074617 (2001-02-01), None
patent: WO200102568 (2001-01-01), None
patent: WO 0181363 (2001-04-01), None
patent: WO200151628 (2001-07-01), None
patent: WO200157188 (2001-08-01), None
patent: WO200181363 (2001-11-01), None
patent: WO200202772 (2002-01-01), None
patent: WO200216593 (2002-02-01), None
patent: WO200220569 (2002-03-01), None
patent: WO200220756 (2002-03-01), None
patent: WO200226826 (2002-04-01), None
patent: WO200229038 (2002-04-01), None
patent: WO200259377 (2002-08-01), None
patent: WO2003003906 (2003-01-01), None
patent: WO2003004989 (2003-01-01), None
patent: WO2003029271 (2003-04-01), None
patent: WO2003035831 (2003-05-01), None
Lazar et al. Transforming Growth Factor alpha: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities. Molecular and Cellular Biology 8(3): 1247-1252, Mar. 1988.*
Burchardt et al., Clinical Chemistry 46(5):595-605 (2000).
Database EMBL, Jan. 27, 2000, “Homo sapiens mRNA; cDNA DKFZp56401278”, Database accession no. AL137517, XP002206400.
Database EMBL, Mar. 25, 2000, “Human DNA sequence from clone RP11-272M24 on chromosome 13”, Database accession no. AL162373, XP002206149, Positions 2090-4650.
Database GENESEQ, Jan. 11, 2002, Human IGFALS homologue-encoding cDNA, Seq ID No.: 1045, PN WO200157188, Database accession no. ABA09269, XP002206401.
International Search Report mailed on Aug. 27, 2002, for PCT patent application No. PCT/US01/26276 filed Aug. 22, 2001, 7 pages.
Ravaioli et al., Cell Proliferation 31(3-4):113-126 (1998).
Afar Daniel E. H.
Challita-Eid Pia
Faris Mary
Hubert Rene S.
Jakobovits Aya
Agensys, Inc.
Harris Alana M.
Morrison & Foerster / LLP
LandOfFree
Nucleic acid and corresponding protein named 158P1D7 useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid and corresponding protein named 158P1D7 useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein named 158P1D7 useful... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3405324